Logotype for Coromandel International Limited

Coromandel International (COROMANDEL) Q3 25/26 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Coromandel International Limited

Q3 25/26 earnings summary

2 Feb, 2026

Executive summary

  • Q3 FY26 saw a challenging environment with global uncertainties, rupee depreciation, and higher raw material costs, but India’s GDP growth remained strong at 7.4% year-over-year, driven by services and manufacturing.

  • Q3 FY26 revenue from operations rose 27% year-over-year to ₹8,779 crore, with EBITDA up 12% to ₹805 crore and PAT down 4% to ₹488 crore.

  • For YTD Dec'25, revenue increased 33% to ₹25,476 crore, EBITDA grew 24% to ₹2,738 crore, and PAT rose 21% to ₹1,784 crore.

  • Board approved unaudited financial results for the quarter and nine months ended December 31, 2025, and declared an interim dividend of ₹9 per equity share.

  • Extended monsoon and crop damage in South India impacted agri input consumption, especially in chili and grape segments, but Rabi sowings and reservoir levels improved.

Financial highlights

  • Consolidated revenue from operations for the quarter: ₹8,779.45 crore, up from ₹6,935.19 crore year-over-year.

  • Net profit after tax for the quarter: ₹652.76 crore, compared to ₹683.12 crore in the same quarter last year.

  • Nine-month consolidated revenue: ₹25,475.88 crore; net profit after tax: ₹2,389.49 crore.

  • Basic EPS for the quarter: ₹17.14; for nine months: ₹62.85.

  • Net debt to equity ratio remained at 0.0 times for both Q3 and YTD periods.

Outlook and guidance

  • Annualized EBITDA guidance for fertilizer segment remains INR 5,000–5,500 per ton, with potential to reach INR 6,500 post-commissioning of new phosphoric acid plant.

  • Crop protection business targets 20–25% annual growth in domestic B2C and continued export-led growth, especially in mancozeb.

  • Management notes that consolidated figures for the current period may not be comparable to previous periods due to the acquisition of NACL.

  • Backward integration projects expected to deliver INR 400 crore annual EBITDA benefit, with no major deviation from initial estimates.

  • Forward-looking statements indicate expectations of continued growth, but actual results may vary due to market, regulatory, and operational factors.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more